M&R Capital Management’s PAVmed PAVM Stock Holding History

M&R Capital Management’s Portfolio PAVM Stock Details PAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$82	Hold	2	–	–	﹤0.01%	575
2024 Q2	$55	Hold	2	–	–	﹤0.01%	545
2024 Q1	$143	Hold	2	–	–	﹤0.01%	542
2023 Q4	$276	Hold	2	–	–	﹤0.01%	625
2023 Q3	$295	Hold	2	–	–	﹤0.01%	610
2023 Q2	$407	Hold	2	–	–	﹤0.01%	604
2023 Q1	$373	Hold	2	–	–	﹤0.01%	595
2022 Q4	$480	Hold	2	–	–	﹤0.01%	583
2022 Q3	$0	Hold	2	–	–	﹤0.01%	449
2022 Q2	$0	Hold	2	–	–	﹤0.01%	446
2022 Q1	$1K	Hold	2	–	–	﹤0.01%	422
2021 Q4	$2K	Hold	2	–	–	﹤0.01%	394
2021 Q3	$8K	Hold	2	–	–	﹤0.01%	345
2021 Q2	$6K	Hold	2	–	–	﹤0.01%	366
2021 Q1	$4K	Hold	2	–	–	﹤0.01%	375
2020 Q4	$2K	Hold	2	–	–	﹤0.01%	414
2020 Q3	$1K	Hold	2	–	–	﹤0.01%	446
2020 Q2	$2K	Sell	2 -54	-96%	-$54K	﹤0.01%	437
2020 Q1	$49K	Buy	+56	New	+$45.8K	0.01%	238

Other funds holding PAVM

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OWP

Obermeyer Wealth Partners Aspen, Colorado $2.17B AUM 19.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

XML Financial Bethesda, Maryland $1.24B AUM 20.4% 1-Year Est. Return

Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

M&R Capital Management's PAVM Position: Q3 2024 in Review

M&R Capital Management held its PAVmed (PAVM) position steady in Q3 2024 at 2 shares worth $82. The position accounts for ﹤0.01% of the portfolio, ranked #575.

M&R Capital Management first reported a position in PAVM in Q1 2020 and has held it in 19 quarters since. The position peaked at $49K in Q1 2020. 19 funds tracked by Wall St. Rank hold PAVM as of Q3 2024.

M&R Capital Management held 2 shares of PAVmed worth $82 as of Q3 2024.
M&R Capital Management left its PAVmed share count unchanged in Q3 2024.
PAVmed made up ﹤0.01% of M&R Capital Management's portfolio in Q3 2024, its #575 holding.
M&R Capital Management first reported a position in PAVmed in Q1 2020 and has held it in 19 quarters since.
M&R Capital Management's PAVmed position peaked at $49K in Q1 2020.
19 funds tracked by Wall St. Rank held PAVmed as of Q3 2024.

Based on M&R Capital Management's 13F filing for Q3 2024, filed 2 Oct 2024.